VanEck Pharmaceutical ETF
143 hedge funds and large institutions have $804M invested in VanEck Pharmaceutical ETF in 2025 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 41 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
7% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 44
46.08% less ownership
Funds ownership: 114.53% → 68.45% (-46%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
143
Holding in Top 10
1
Calls
$7.55M
Puts
$5.33M
Top Buyers
| 1 | +$67M | |
| 2 | +$59.4M | |
| 3 | +$39.7M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$18.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.2M |
Top Sellers
| 1 | -$105M | |
| 2 | -$36.8M | |
| 3 | -$24.7M | |
| 4 |
RAM
Revere Asset Management
Dallas,
Texas
|
-$15.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$6.85M |
